4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Nasal Congestion: new trials by email Literature Review of Nasal Congestion trials Research Report on Nasal Congestion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19 BNO 1030, Standard care - Covid19, Nasopharyngitis | Phase 4 | Completed | Ivano-Frankivsk National Medical University | 133 | 2020-05-01 | 2021-03-15 |
| Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion Test strip, Placebo strip, Nasal spray - Nasal Congestion | Phase 4 | Completed | GlaxoSmithKline | 28 | 2013-08-05 | 2017-08-02 |
| Efficacy and Safety of Sinutab on Subjects in the Setting of a Common Cold Pseudoephedrine/Paracetamol - Common Cold, Headache | Phase 4 | Completed | McNeil AB | 469 | 2007-01-01 | 2012-07-10 |
| To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses Diphenhydramine 50 mg, Diphenhydramine 25 mg, Pseudoephedrine 120 mg - Nasal Congestion | Phase 4 | Completed | Johnson & Johnson Consumer and Personal Products Worldwide | 1021 | 2006-11-01 | 2011-08-22 |
Nasal Obstruction (4) · Anosmia (1) · COVID-19 (1) · Common Cold (1) · Cough (1) · Fever (1) · Headache (1) · Myalgia (1) · Nasopharyngitis (1) · Rhinitis, Allergic, Seasonal (1)
Airway Obstruction (4) · Nose Diseases (4) · Otorhinolaryngologic Diseases (4) · Respiration Disorders (4) · Respiratory Insufficiency (4) · Respiratory Tract Diseases (4) · Infections (2) · Neurologic Manifestations (2) · Pain (2) · Pathological Conditions, Signs and Symptoms (2) · RNA Virus Infections (2) · Respiratory Tract Infections (2) · Signs and Symptoms (2) · Virus Diseases (2) · Body Temperature Changes (1)
Pseudoephedrine (2) · Acetaminophen (1) · Diphenhydramine (1) · Nasal Sprays (1) · Standard of Care (1) · acetaminophen, phenylpropanolamine, phenyltoloxamine drug combination (1) · imupret (1)
GlaxoSmithKline (1) · Ivano-Frankivsk National Medical University (1) · Johnson & Johnson Consumer and Personal Products Worldwide (1) · McNeil AB (1)
Belgium (1) · Ukraine (1) · United Kingdom (1) · United States (1)
Elisabeth A Kruse, PhD (1) · Melissa Israel, BS (1) · Vasyl Popovych, Professor (1)